Correlation between LUTS (AUA-SS) and erectile dysfunction (SHIM) in an age-matched racially diverse male population: Data from the Prostate Cancer Awareness Week (PCAW)

International Journal of Impotence Research

Volumn 17, Issue 4, 2005, Pages 370-374

  Barqawi, A ^a   O'Donnell, C ^a   Kumar, R ^a   Koul, H ^a   Crawford, E D ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Erectile dysfunction; LUTS; Race; Testosterone

Indexed keywords

TESTOSTERONE;

ADULT; AFRICAN AMERICAN; AGED; AGING; AMERICAN UROLOGICAL ASSOCIATION SYMPTOM INDEX; ARTICLE; CANCER SCREENING; CAUCASIAN; COMORBIDITY; CORRELATION COEFFICIENT; DISEASE SEVERITY; ERECTILE DYSFUNCTION; HUMAN; HYPOGONADISM; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; QUESTIONNAIRE; RACE; RISK FACTOR; SCORING SYSTEM; SEXUAL FUNCTION; SEXUAL HEALTH INVENTORY FOR MEN; SMOKING HABIT; TESTOSTERONE BLOOD LEVEL; URINARY TRACT DISEASE;

ADULT; AFRICAN AMERICANS; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; COMORBIDITY; EUROPEAN CONTINENTAL ANCESTRY GROUP; HEALTH STATUS; HUMANS; IMPOTENCE; MALE; MASS SCREENING; MIDDLE AGED; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; QUESTIONNAIRES; RISK FACTORS; SMOKING;

EID: 22644447565     PISSN: 09559930     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijir.3901340     Document Type: Article

References (30)

1. Rosen R et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Prog Urol 2004; 14: 332-344.
2. McKinlay JB. The worldwide prevalence and epidemiology of erectile dysfunction. Int J Impot Res 2000; 12(Suppl 4): S6-S11.
3. Rosen R et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol 2003; 44: 637-649.
4. Hansen BL. urinary tract symptoms (LUTS) and sexual function in both sexes. Eur Urol 2004; 46: 229-234.
5. Braun M et al. Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'. Int J Impot Res 2000; 12: 305-311.
6. Carbone Jr DJ, Hodges S. Medical therapy for benign prostatic hyperplasia: sexual dysfunction and impact on quality of life. Int J Impot Res 2003; 15: 299-306.
7. Chung WS et al. Lower urinary tract symptoms and sexual dysfunction in community-dwelling men. Mayo Clin Proc 2004; 79: 745-749.
8. Elliott SP et al. Obstructive lower urinary tract symptoms correlate with erectile dysfunction. Urology 2004; 63: 1148-1152.
9. Gacci M et al. Urinary symptoms, quality of life and sexual function in patients with benign prostatic hypertrophy before and after prostatectomy: a prospective study. BJU Int 2003; 91: 196-200.
10. Barry MJ et al. Correlation of the American Urological Association symptom index with self-administered versions of the Madsen-Iversen, Boyarsky and Maine Medical Assessment Program symptom indexes. Measurement Committee of the American Urological Association. J Urol 1992; 148: 1558-1563, discussion 1564.
11. Cappelleri JC et al. Relationship between patient self-assessment of erectile dysfunction and the sexual health inventory for men. Clin Ther 2001; 23: 1707-1719.
12. Calais Da Silva F et al. Relative importance of sexuality and quality of life in patients with prostatic symptoms. Results of an international study. Eur Urol 1997; 31: 272-280.
13. Macfarlane GJ et al. The relationship between sexual life and urinary condition in the French community. J Clin Epidemiol 1996; 49: 1171-1176.
14. Frankel SJ et al. Sexual dysfunction in men with lower urinary tract symptoms. J Clin Epidemiol 1998; 51: 677-685.
15. Feldman HA et al. Construction of a surrogate variable for impotence in the Massachusetts Male Aging Study. J Clin Epidemiol 1994; 47: 457-467.
16. Ross R et al. Serum testosterone levels in healthy young black and white men. J Natl Cancer Inst 1986; 76: 45-48.
17. Kubricht III WS et al. Serum testosterone levels in African-American and white men undergoing prostate biopsy. Urology 1999; 54: 1035-1038.
18. Olapade-Olaopa EO et al. Androgen receptor protein expression in prostatic tissues in Black and Caucasian men. Prostate 2004; 59: 460-468.
19. Anderson RA et al. 7Alpha-methyl-19-nortestosterone maintains sexual behavior and mood in hypogonadal men. J Clin Endocrinol Metab 1999; 84: 3556-3562.
20. Gillum RF. Coronary heart disease in black populations. I. Mortality and morbidity. Am Heart J 1982; 104: 839-851.
21. Henderson SO, Bretsky P, Henderson BE, Stram DO. Risk factors for cardiovascular and cerebrovascular death among African Americans and Hispanics in Los Angeles, California. Acad Emerg Med 2001; 8: 1163-1172.
22. Kountz D, Assiamah A. Diabetes mellitus in African Americans: impact of race on medical complications, sexual function, and general well-being. Med Aspects Hum Sex 2001; 1: 13-23.
23. Kountz DS, Levine SL. Cardiovascular risk profiling in blacks: don't forget the lipids. Am Fam Physician 1998; 58: 1541-1542.
24. Davidson JM et al. Hormonal changes and sexual function in aging men. J Clin Endocrinol Metab 1983; 57: 71-77.
25. Ahn HS, Park CM, Lee SW. The clinical relevance of sex hormone levels and sexual activity in the ageing male. BJU Int 2002; 89: 526-530.
26. Shibata Y et al. Changes in the endocrine environment of the human prostate transition zone with aging: simultaneous quantitative analysis of prostatic sex steroids and comparison with human prostatic histological composition. Prostate 2000; 42: 45-55.
27. Jeremy JY et al. Platelets, oxidant stress and erectile dysfunction: a hypothesis. Cardiovasc Res 2000; 46: 50-54.
28. Haidinger G et al. Risk factors for lower urinary tract symptoms in elderly men. For the Prostate Study Group of the Austrian Society of Urology. Eur Urol 2000; 37: 413-420.
29. Seidman SN. Exploring the relationship between depression and erectile dysfunction in aging men. J Clin Psychiatry 2002; 63(Suppl 5): 5-12, discussion 23-25.
30. Kassabian VS. Sexual function in patients treated for benign prostatic hyperplasia. Lancet 2003; 361: 60-62.